Skip to main content

[caption id="attachment_24161" align="aligncenter" width="900"] Mechanism of action of aromatase inhibitors in post menopausal women and in breast cancer[/caption] While recent medical discoveries, from drugs to imaging techniques, continue to revolutionize cancer care, none of them would be possible without foundations having been laid years, or even...

[vc_row][vc_column][vc_single_image image="19162" img_size="full"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Triple-negative breast cancer, one of the deadliest and most aggressive forms of breast cancer, spreads quickly, is resistant to many chemotherapies and is likely to reoccur even after a seemingly successful round of therapies. The cause for the latter is the resiliency...

Testing new treatments is key to successfully treating cancer. Unfortunately, the current model for conducting clinical trials — evaluating the effectiveness of therapies on human subjects — is inefficient, expensive and suffers from high failure rates. To overcome these challenges, the practice of adaptive trials is...